Elevation Oncology Statistics
Total Valuation
ELEV has a market cap or net worth of $35.91 million. The enterprise value is -$36.14 million.
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025, before market open.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ELEV has 59.12 million shares outstanding. The number of shares has increased by 81.44% in one year.
Current Share Class | 59.12M |
Shares Outstanding | 59.12M |
Shares Change (YoY) | +81.44% |
Shares Change (QoQ) | +0.15% |
Owned by Insiders (%) | 0.27% |
Owned by Institutions (%) | 51.57% |
Float | 39.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.52 |
P/TBV Ratio | 0.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.77, with a Debt / Equity ratio of 0.45.
Current Ratio | 17.77 |
Quick Ratio | 17.39 |
Debt / Equity | 0.45 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.11 |
Financial Efficiency
Return on equity (ROE) is -63.67% and return on invested capital (ROIC) is -27.24%.
Return on Equity (ROE) | -63.67% |
Return on Assets (ROA) | -25.46% |
Return on Invested Capital (ROIC) | -27.24% |
Return on Capital Employed (ROCE) | -41.85% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.45M |
Employee Count | 29 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ELEV has paid $43,000 in taxes.
Income Tax | 43,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.31% in the last 52 weeks. The beta is 1.32, so ELEV's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | -78.31% |
50-Day Moving Average | 0.66 |
200-Day Moving Average | 1.42 |
Relative Strength Index (RSI) | 43.45 |
Average Volume (20 Days) | 1,315,380 |
Short Selling Information
The latest short interest is 8.77 million, so 14.83% of the outstanding shares have been sold short.
Short Interest | 8.77M |
Short Previous Month | 8.94M |
Short % of Shares Out | 14.83% |
Short % of Float | 22.30% |
Short Ratio (days to cover) | 2.00 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.01M |
Pretax Income | -39.66M |
Net Income | -41.95M |
EBITDA | -41.98M |
EBIT | -42.01M |
Earnings Per Share (EPS) | -$0.79 |
Full Income Statement Balance Sheet
The company has $103.07 million in cash and $31.02 million in debt, giving a net cash position of $72.05 million or $1.22 per share.
Cash & Cash Equivalents | 103.07M |
Total Debt | 31.02M |
Net Cash | 72.05M |
Net Cash Per Share | $1.22 |
Equity (Book Value) | 69.36M |
Book Value Per Share | 1.17 |
Working Capital | 99.40M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -38.34M |
Capital Expenditures | n/a |
Free Cash Flow | -38.34M |
FCF Per Share | -$0.65 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |